Effect of detoxification of buprenorphine gum versus buprenorphine sublingual tablet in addicts

Effect of detoxification of buprenorphine gum versus buprenorphine sublingual tablet in addicts: a randomized clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N607

Enrollment

100

Registered

2026-05-04

Start date

2026-06-22

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Withdrawal syndrome. Opioid dependence with withdrawal

Interventions

Intervention 1: Intervention group: Buprenorphine gum 8 mg daily for at most 35 days. Intervention 2: Control group: Buprenorphine sublingual tablet 8 mg daily for at most 35 days.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age of 18 to 65 years, Addiction to opium,

Exclusion criteria

Exclusion criteria: Using methadone

Design outcomes

Primary

Measure	Time frame
Withdrawal syndrome. Timepoint: 35 days after the intervention. Method of measurement: By taking history and physical examination.;The rate of patients’ satisfaction. Timepoint: 35 days after the intervention. Method of measurement: Using standard Satisfaction Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSalman Saeidi

Hamedan University of Medical Sciences

salman.saeidi@gmail.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026